Clinical Trials
2 trialsNCT03041701 2022-04-14
Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT00924950 2019-04-18
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
University of California, San Francisco
Phase 4 Terminated